NEJM Interviews cover image

NEJM Interview: Peter Ubel on strategies for protecting patients from high out-of-pocket costs for drugs with questionable benefits.

NEJM Interviews

00:00

Exploring Policies for Drug Price Regulation and Patient Cost Relief

This chapter examines potential federal policy measures to regulate new drug prices, emphasizing cost-effectiveness analysis akin to UK's system. It discusses Medicare's role in setting price thresholds and the bipartisan effort to tackle high medication costs impacting Americans.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app